Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer

Stopped early · Phase 4

Conditions studied: Prostate Cancer

In brief

This research study looks at Testosterone levels in patients receiving Trelstar versus those receiving Lupron or Zoladex. These drugs have been approved for treatment of Prostate Cancer by the FDA.

Key facts

Study ID
NCT02749825
Run by
Pharmatech
People needed
41
Starts
2002-09-01
Expected to finish
2006-07-01
Last updated by the study team
2016-04-25

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.